-
-
-
-
-
-
-
PacBio reports fourth quarter revenue growth of 14% year-over-year
-
-
-
-
-
-
-
QIAGEN launches long read sequencing panels for complex genomic analysis
-
-
-
-
-
-
-
Pacific Bio (PACB) Reports Prelim Q1 Revenue, Affirms FY25 Guidance
-
-
-
-
-
-
-
Pacific Bio (PACB) Tops Q3 EPS by 5c
-
-
-
-
-
-
-
Pacific Biosciences of California (PACB) PT Lowered to $8 at Scotiabank
-
-
-
-
-
-
-
PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively
-
-
-
-
-
-
-
PacBio Enters into Agreement to Acquire Apton Biosystems to Accelerate the Development of a Next Generation, High Throughput, Short-read Sequencer
-
1,197,266 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

